iBio, Inc. (IBIO)

iBio, Inc. Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	47.63	8.58	14.21	4.3	22.68	77.4
Short-Term Investments	27.17	-	-	-	10.85	19.57
Cash & Short-Term Investments	74.8	8.58	14.21	4.3	33.52	96.97
Cash Growth	1408.31%	-39.61%	230.39%	-87.17%	-65.43%	75.96%
Accounts Receivable	-	-	-	-	1	0.43
Other Receivables	-	0.11	0.71	0.87	5.1	5.1
Total Trade Receivables	-	0.11	0.71	0.87	6.1	5.53
Inventory	-	-	-	-	-	0.03
Other Current Assets	2.45	1.03	0.75	21.09	5.45	2.07
Total Current Assets	77.25	9.72	15.67	26.26	45.07	104.6
Net Property, Plant & Equipment	5.08	5.28	6.37	7.55	4.44	34.74
Other Intangible Assets	1.83	6.85	5.37	5.39	4.85	0.95
Other Long-Term Assets	1.68	1.33	1.32	2.01	45.04	6.68
Total Assets	85.83	23.19	28.73	41.21	99.41	146.97

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	3.04	2.19	0.36	1.85	4.26	2.25
Accrued Expenses	1.79	1.35	2.03	4.56	3.76	3
Short-Term Debt	-	-	0.12	12.94	-	-
Current Portion of Long-Term Debt	-	0.83	0.4	0.16	22.16	0.6
Current Portion of Leases	0.53	0.54	0.74	0.66	0.09	0.37
Unearned Revenue	1.15	1.2	0.2	-	0.1	0.42
Other Current Liabilities	-	-	-	1.94	0.06	-
Total Current Liabilities	6.5	6.11	3.84	22.11	30.44	6.65
Long-Term Debt	-	-	0.83	0.24	-	-
Long-Term Leases	1.79	2.2	2.74	3.48	3.51	31.76
Other Long-Term Liabilities	-	-	-	-	1.97	-
Total Long-Term Liabilities	1.79	2.2	3.57	3.72	5.49	31.76
Total Liabilities	8.3	8.31	7.41	25.83	35.92	38.4

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	0.04	0.02	0.01	0	0.01	0.01
Additional Paid-in Capital	432.19	347.09	335.16	304.32	287.62	282.27
Accumulated Other Comprehensive Income	-0.02	-	-	-	-0.21	-0.06
Retained Earnings	-354.67	-332.22	-313.85	-288.94	-223.93	-173.63
Total Common Shareholders' Equity	77.54	14.88	21.32	15.38	63.49	108.59
Minority Interest	-	-	-	-	-	-0.02
Shareholders' Equity	77.54	14.88	21.32	15.38	63.49	217.15
Total Liabilities & Equity	85.83	23.19	28.73	41.21	99.41	146.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	2.33	3.57	4.82	17.48	25.77	32.72
Net Cash (Debt)	72.47	5.01	9.39	-13.17	7.76	64.25
Net Cash Growth	11241.47%	-46.62%	-	-	-87.93%	189.37%
Net Cash Per Share	1.01	0.48	2.45	-21.53	17.79	164.22
Book Value	77.54	14.88	21.32	15.38	63.49	108.59
Book Value Per Share	1.08	1.42	5.57	25.13	145.59	277.53
Tangible Book Value	75.71	8.03	15.96	9.99	58.63	107.63
Tangible Book Value Per Share	1.06	0.77	4.16	16.33	134.47	275.10

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error